The Mediterranean diet increases glucagon-like peptide 1 and oxyntomodulin compared with a vegetarian diet in patients with type 2 diabetes: A randomized controlled cross-over trial.
Study Goal
The researchers aimed to compare the effects of a high-fibre vegetarian diet (HFV) and a Mediterranean diet (MED) on hunger-satiety perception, glucose homeostasis, and appetite-related hormone release in overweight/obese individuals with type 2 diabetes.
Results Summary
The study found that the MED meal resulted in higher levels of GLP-1 and oxyntomodulin, better glucose control, and a delayed second GLP-1 peak compared to the HFV meal, though self-reported appetite scores did not differ significantly between the two diets.
Population
Overweight/obese individuals with type 2 diabetes (12 subjects, male to female ratio = 7:5, mean age 63 ± 8.5 years).
Effective Dosage
Not specified (isocaloric meals were used).
Duration
Two meal interventions with a 1-week washout period.
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Mediterranean diet (MED) meal | increase | GLP-1 levels | overweight/obese subjects with type 2 diabetes (T2D) | p < 0.022 | significantly higher | #1 |
Mediterranean diet (MED) meal | increase | oxyntomodulin levels | overweight/obese subjects with type 2 diabetes (T2D) | p < 0.023 | significantly higher | #2 |
Mediterranean diet (MED) meal | increase | GLP-1 | overweight/obese subjects with type 2 diabetes (T2D) | p < 0.05 | delayed, significantly higher second peak | #3 |
Mediterranean diet (MED) meal | decrease | glucose profile | overweight/obese subjects with type 2 diabetes (T2D) | p < 0.039 | related to lower glucose profile | #4 |
Mediterranean diet (MED) meal | no change | self-reported VAS scores | overweight/obese subjects with type 2 diabetes (T2D) | no significant change | did not observe significant changes | #5 |
Mediterranean diet (MED) meal | no change | insulin trend | overweight/obese subjects with type 2 diabetes (T2D) | no significant change | did not observe significant changes | #6 |
high-fibre vegetarian diet (HFV) meal | no change | self-reported VAS scores | overweight/obese subjects with type 2 diabetes (T2D) | no significant change | did not observe significant changes | #7 |
high-fibre vegetarian diet (HFV) meal | no change | insulin trend | overweight/obese subjects with type 2 diabetes (T2D) | no significant change | did not observe significant changes | #8 |
AIM: To compare a Mediterranean diet (MED) with a high-fibre vegetarian diet (HFV) in terms of hunger-satiety perception through post-prandial assessment of appetite-related hormones glucagon-like peptide 1 (GLP-1) and oxyntomodulin, as well as self-rated visual analogue scale (VAS) quantification, in overweight/obese subjects with type 2 diabetes (T2D). MATERIALS AND METHODS: Twelve T2D subjects (Male to female ratio = 7:5), mean age 63 ± 8.5 years, were enrolled in a randomized, controlled, crossover study. Participants consumed an MED meal as well as an isocaloric meal rich in complex carbohydrate as well as an isocaloric MED meal in two different visits with a 1-week washout period between the two visits. Appetite ratings, glucose/insulin, and gastrointestinal hormone concentrations were measured at fasting and every 30' until 210' following meal consumption. RESULTS: GLP-1 and oxyntomodulin levels were significantly higher following MED meal compared with HFV meals (210' area under the curve, p < 0.022 and p < 0.023, respectively). Both MED and HFV meal resulted in a biphasic pattern of GLP-1 and oxyntomodulin, although MED meal was related to a delayed, significantly higher second GLP-1 peak at 150' compared with that of HFV meal (p < 0.05). MED meal was related to lower glucose profile compared with HFV meal (p < 0.039), whereas we did not observe significant changes in terms of self-reported VAS scores and insulin trend. CONCLUSIONS: In T2D overweight/obese subjects, an MED meal is more effective than a HFV meal in terms of post-prandial plasma glucose homoeostasis and GLP-1 and oxyntomodulin release. These changes were not confirmed by VAS appetite self-assessment over a 210' period.